title: The RAG Model: A New Paradigm for Genetic Risk Stratification in Multiple Myeloma.
abstract: Molecular studies have shown that multiple myeloma is a highly genetically heterogonous disease which may manifest itself as any number of diverse subtypes each with variable clinicopathological features and outcomes. Given this genetic heterogeneity, a universal approach to treatment of myeloma is unlikely to be successful for all patients and instead we should strive for the goal of personalised therapy using rationally informed targeted strategies. Current DNA sequencing technologies allow for whole genome and exome analysis of patient myeloma samples that yield vast amounts of genetic data and provide a mutational overview of the disease. However, the clinical utility of this information currently lags far behind the sequencing technology which is increasingly being incorporated into clinical practice. This paper attempts to address this shortcoming by proposing a novel genetically based "traffic-light" risk stratification system for myeloma, termed the RAG (Red, Amber, Green) model, which represents a simplified concept of how complex genetic data may be compressed into an aggregate risk score. The model aims to incorporate all known clinically important trisomies, translocations, and mutations in myeloma and utilise these to produce a score between 1.0 and 3.0 that can be incorporated into diagnostic, prognostic, and treatment algorithms for the patient.
authors.affiliation: Brighton and Sussex Medical School, Sussex University, Falmer, Brighton BN1 9PS, UK.
authors.forename: Steven M
authors.initials: SM
authors.lastname: Prideaux
authors.affiliation: Brighton and Sussex Medical School, Sussex University, Falmer, Brighton BN1 9PS, UK.
authors.forename: Emma
authors.initials: E
authors.lastname: Conway O'Brien
authors.affiliation: Brighton and Sussex Medical School, Sussex University, Falmer, Brighton BN1 9PS, UK.
authors.forename: Timothy J
authors.initials: TJ
authors.lastname: Chevassut